Singapore - English - HSA (Health Sciences Authority)

msd pharma (singapore) pte. ltd. - (desloratadine coated granules): desloratadine, micronized - tablet, orally disintegrating - 2.5mg - (desloratadine coated granules): desloratadine, micronized 2.5mg

Malta - English - Medicines Authority

cipla europe n.v. uitbreidingstraat 80, 2600 antwerp, belgium - desloratadine - film-coated tablet - desloratadine 5 mg - antihistamines for systemic use

Israel - English - Ministry of Health

trima israel pharmaceutical products maabarot ltd - desloratadine - tablets - desloratadine 5 mg - desloratadine - desloratadine - desloratadine - trima tablets are indicated in adults and adolescents aged 12 yars and older for the relief of symptoms associated with: - allergic rhinitis, - urticaria

United States - English - NLM (National Library of Medicine)

avkare - desloratadine (unii: fvf865388r) (desloratadine - unii:fvf865388r) - desloratadine 5 mg - desloratadine tablets are indicated for the relief of the nasal and non-nasal symptoms of seasonal allergic rhinitis in patients 12 years of age and older. desloratadine tablets are indicated for the relief of the nasal and non-nasal symptoms of perennial allergic rhinitis in patients 12 years of age and older. desloratadine tablets are indicated for the symptomatic relief of pruritus, reduction in the number of hives, and size of hives, in patients with chronic idiopathic urticaria 12 years of age and older. - desloratadine tablets are contraindicated in patients who are hypersensitive to this medication or to any of its ingredients or to loratadine [see warnings and precautions ( 5.1) and adverse reactions ( 6.2)]. desloratadine tablets are contraindicated in patients who are hypersensitive to this medication or to any of its ingredients or to loratadine [see warnings and precautions ( 5.1) and

United States - English - NLM (National Library of Medicine)

virtus pharmaceuticals - desloratadine (unii: fvf865388r) (desloratadine - unii:fvf865388r) - desloratadine 5 mg - desloratadine tablets are indicated for the relief of the nasal and non-nasal symptoms of seasonal allergic rhinitis in patients 12 years of age and older. desloratadine tablets are indicated for the relief of the nasal and non-nasal symptoms of perennial allergic rhinitis in patients 12 years of age and older. desloratadine tablets are indicated for the symptomatic relief of pruritus, reduction in the number of hives, and size of hives, in patients with chronic idiopathic urticaria 12 years of age and older. desloratadine tablets are contraindicated in patients who are hypersensitive to this medication or to any of its ingredients or to loratadine [see warnings and precautions (5.1) and adverse reactions (6.2) ]. risk summary the limited available data with desloratadine in pregnant women are not sufficient to inform a drug-associated risk for major birth defects and miscarriage. there are no adequate and well-controlled studies in pregnant women. desloratadine given during organogenesis to pregnant rats was

United States - English - NLM (National Library of Medicine)

bryant ranch prepack - desloratadine (unii: fvf865388r) (desloratadine - unii:fvf865388r) - desloratadine 5 mg - desloratadine tablets are indicated for the relief of the nasal and non-nasal symptoms of seasonal allergic rhinitis in patients 12 years of age and older. desloratadine tablets are indicated for the relief of the nasal and non-nasal symptoms of perennial allergic rhinitis in patients 12 years of age and older. desloratadine tablets are indicated for the symptomatic relief of pruritus, reduction in the number of hives, and size of hives, in patients with chronic idiopathic urticaria 12 years of age and older. desloratadine tablets are contraindicated in patients who are hypersensitive to this medication or to any of its ingredients or to loratadine [see warnings and precautions (5.1) and adverse reactions (6.2) ]. pregnancy category c: there are no adequate and well-controlled studies in pregnant women. because animal reproduction studies are not always predictive of human response, desloratadine should be used during pregnancy only if clearly needed. desloratadine was not teratogenic in rats or rabbits at a

United States - English - NLM (National Library of Medicine)

belcher pharmaceuticals,llc - desloratadine (unii: fvf865388r) (desloratadine - unii:fvf865388r) - desloratadine 5 mg - desloratadine tablets are indicated for the relief of the nasal and non-nasal symptoms of seasonal allergic rhinitis in patients 12 years of age and older. desloratadine tablets are indicated for the relief of the nasal and non-nasal symptoms of perennial allergic rhinitis in patients 12 years of age and older. desloratadine tablets are indicated for the symptomatic relief of pruritus, reduction in the number of hives, and size of hives, in patients with chronic idiopathic urticaria 12 years of age and older. - desloratadine tablets are contraindicated in patients who are hypersensitive to this medication or to any of its ingredients or to loratadine [see warnings and precautions ( 5.1) and adverse reactions ( 6.2)]. desloratadine tablets are contraindicated in patients who are hypersensitive to this medication or to any of its ingredients or to loratadine [see warnings and precautions ( 5.1) and

Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

sandoz sa-nv - desloratadine 5 mg - film-coated tablet - 5 mg - desloratadine 5 mg - desloratadine

United States - English - NLM (National Library of Medicine)

dr. reddy's laboratories limited - desloratadine (unii: fvf865388r) (desloratadine - unii:fvf865388r) - desloratadine 2.5 mg - desloratadine orally disintegrating tablets are indicated for the relief of the nasal and non-nasal symptoms of seasonal allergic rhinitis in patients 2 years of age and older. desloratadine orally disintegrating tablets are indicated for the relief of the nasal and non-nasal symptoms of perennial allergic rhinitis in patients 6 months of age and older. desloratadine orally disintegrating tablets are contraindicated in patients who are hypersensitive to this medication or to any of its ingredients or to loratadine [see warnings and precautions (5.1) and adverse reactions (6.2) ] risk summary the limited available data with desloratadine in pregnant women are not sufficient to inform a drug-associated risk for major birth defects and miscarriage. there are no adequate and well-controlled studies in pregnant women. desloratadine given during organogenesis to pregnant rats was not teratogenic at the summed area under the concentration-time curve (auc)-based exposures of desloratadine and its metabo

New Zealand - English - Medsafe (Medicines Safety Authority)

bayer new zealand limited - desloratadine 5mg;   - film coated tablet - 5 mg - active: desloratadine 5mg   excipient: calcium hydrogen phosphate dihydrate carnauba wax maize starch opadry blue 32b10817 opadry clear ys-1-19025-a powdered cellulose purified talc white beeswax - the relief of symptoms associated with seasonal and perennial allergic rhinitis, such as sneezing, nasal discharge and itching, congestion/stuffiness, as well as ocular itching, tearing and redness, itching of palate and coughing.